Tech Company Financing Transactions

NexImmune Funding Round

NexImmune, operating out of Gaithersburg, raised $21.7 million from private investors.

Transaction Overview

Company Name
Announced On
12/28/2017
Transaction Type
Venture Equity
Amount
$21,730,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 69 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
9119 Gaither Rd.
Gaithersburg, MD 20877
USA
Email Address
Overview
NexImmune is an early stage biopharmaceutical company developing novel immuno-therapeutics based on the proprietary Artificial IMmune (AIMTM) technology. The AIM technology provides an important advance in the development of immuno-therapies for a variety of cancers and other diseases.
Profile
NexImmune LinkedIn Company Profile
Social Media
NexImmune Company Twitter Account
Company News
NexImmune News
Facebook
NexImmune on Facebook
YouTube
NexImmune on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Scott Carmer
  Scott Carmer LinkedIn Profile  Scott Carmer Twitter Account  Scott Carmer News  Scott Carmer on Facebook
Chief Financial Officer
Alain Cappeluti
  Alain Cappeluti LinkedIn Profile  Alain Cappeluti Twitter Account  Alain Cappeluti News  Alain Cappeluti on Facebook
Chief Operating Officer
Kristi Jones
  Kristi Jones LinkedIn Profile  Kristi Jones Twitter Account  Kristi Jones News  Kristi Jones on Facebook
Vice President
Alex Matschiner
  Alex Matschiner LinkedIn Profile  Alex Matschiner Twitter Account  Alex Matschiner News  Alex Matschiner on Facebook
Vice President
Mathias Oelke
  Mathias Oelke LinkedIn Profile  Mathias Oelke Twitter Account  Mathias Oelke News  Mathias Oelke on Facebook
VP - Bus. Development
Naimish Pandya
  Naimish Pandya LinkedIn Profile  Naimish Pandya Twitter Account  Naimish Pandya News  Naimish Pandya on Facebook
VP - Engineering
Daniel Bednárik
  Daniel Bednárik LinkedIn Profile  Daniel Bednárik Twitter Account  Daniel Bednárik News  Daniel Bednárik on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/28/2017: Polyverse venture capital transaction
Next: 12/28/2017: CytoVale venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary